All In MedTech

Device Trial Radar · NCT00746135

TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study

TRI-V Resynchronization in Paced Heart Failure Patients With ICD Indication.

Last checked: Nov 20, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Nov 2007

Primary completion

Oct 2010

Study completion Dec 2012

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Sep 3, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

It's the aim of this study to investigate the impact of Right Ventricular (RV) lead position (RV-apex, His bundle area, RV-apex+His bundle area) in combination with individually optimized Left Ventricular (LV) lead placement and CRT timing on the outcome of cardiac resynchronization therapy (CRT).

Conditions

  • Heart Failure

Interventions

  • Device ImplantationDevice

    RV apical pacing lead, RV pacing lead at HIS bundle position, LV pacing lead implantation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement according to Packer's "Heart Failure Clinical Composite Respond"Time frame: 12 months post implant

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Departement of Cardiology - Electrophysiology- Heart Centre Osnabrück - Bad Rothenfelde

    Bad Rothenfelde, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.